BMC Infectious Diseases is calling for submissions to our Collection on Bacteriophages against multi-drug resistant bacteria.
Bacteriophages, or phages for short, are viruses that infect and kill bacteria. Bacteriophages have gained a lot of attention in recent years due to their potential as an alternative to antibiotics in the fight against multi-drug resistant bacteria.
Bacterial resistance to antibiotics has become a major public health issue worldwide, leading to increased morbidity, mortality, and healthcare costs. Phages offer a promising solution to this problem, as they are highly specific to their bacterial host and can kill bacteria without harming the body's own cells.
It is crucial to continue advancing our collective understanding of bacteriophages' usefulness as a tool against multi-drug resistant bacteria because the problem of antibiotic resistance is not going away. Recent interdisciplinary research has revealed important insights into the mechanisms of phage-bacteria interactions and the design of effective phage therapy protocols. These advances have paved the way for the development of novel treatments that could save lives and reduce the burden of infectious diseases worldwide. Looking to the future, continued research into phage therapy could lead to even more breakthroughs, such as the creation of personalized phage therapies tailored to individual patients and the development of new methods for producing and delivering phages effectively.
In this Collection, we invite researchers and experts in the field of infectious diseases to contribute original research articles on the use of phages as a treatment for multi-drug resistant bacteria. We welcome submissions that explore the mechanisms of phage-bacteria interactions, the development of phage therapy protocols, and the clinical applications of phage therapy in humans and animals.
We encourage authors to submit high-quality, rigorous research that advances our understanding of phage biology and their potential as an alternative to antibiotics. The scope of this Collection includes but is not limited to:
- Phage therapy for ESKAPE bacteria
- Developing phage-based strategies to combat antimicrobial resistance
- Understanding phage-microbiome interactions for improved therapy
- The potential of lytic phages as a tool for fighting drug resistance
- Phageome analysis for identification of novel phages for therapy
- Bacteriophages as an antibiotic replacement in the antimicrobial crisis
Image credit: © iLexx / Getty Images / iStock